comparemela.com

Page 10 - Sylvia Wimmer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Heidelberg Pharma and Chiome Bioscience Sign Exclusive, Target-Specific Research and Option Agreemen

Heidelberg Pharma AG / Key word(s): AllianceHeidelberg Pharma and Chiome Bioscience Sign Exclusive, Target-Specific Research and Option Agreement for the Development of an Antibody Drug Conjugate13-Jul-2022 / 09:58 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014,.

Sylvia wimmerChiome bioscienceHeidelberg pharma amanitinHeidelberg pharmaMc servicesAgreement for the developmentChiome bioscience incFrankfurt stock exchangeHeidelberg pharma research gmbDistribution servicesChiome bioscience sign exclusiveTarget specific researchOption agreementAntibody drugPharma research gmbhHeidelberg pharma research

DGAP-News: Heidelberg Pharma AG: Heidelberg Pharma Reports on First Half-Year 2022

DGAP-News: Heidelberg Pharma AG / Key word(s): Half Year Report Heidelberg Pharma AG: Heidelberg Pharma Reports on First Half-Year 20.

United statesHong kongTel avivSri lankaUnited kingdomSouth koreaSouth australiaRepublic ofRepublic of chinaTaiwan generalMacau generalSylvia wimmerJan schmidtHeidelberg pharmaHeidelberg pharma groupRedhill biopharma ltd

Heidelberg Pharma AG: Heidelberg Pharma Reports on First Half-Year 2022

12.07.2022 Heidelberg Pharma AG: Heidelberg Pharma Reports on First Half-Year 2022 | Heidelberg Pharma AG | News | Nachricht | Mitteilung

United statesHong kongTel avivSri lankaUnited kingdomSouth koreaSouth australiaRepublic ofRepublic of chinaTaiwan generalMacau generalSylvia wimmerJan schmidtHeidelberg pharmaHeidelberg pharma groupRedhill biopharma ltd

Heidelberg Pharma Reports Outcome of the Annual General Meeting 2022

28.06.2022 Heidelberg Pharma Reports Outcome of the Annual General Meeting 2022 | Heidelberg Pharma AG | News | Nachricht | Mitteilung

Sylvia wimmerJan schmidtChristof hettichHeidelberg pharmaMc servicesArticles of associationCorporate communicationsFrankfurt stock exchangeHeidelberg pharma research gmbPharma reports outcomeAnnual general meetingExecutive management boardSupervisory boardContingent capitalJan schmidt brandManagement board

Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2022

28.04.2022 Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2022 | Heidelberg Pharma AG | News | Nachricht | Mitteilung

South australiaUnited statesTel avivUnited kingdomSylvia wimmerJan schmidtHeidelberg pharmaMc servicesHeidelberg pharma groupFrankfurt stock exchangeFinancial supervisory authority bafinMinistry of economic affairsRedhill biopharma ltdAmerican association for cancer researchHuadong medicine co ltdGmbh co

vimarsana © 2020. All Rights Reserved.